Eledon Pharmaceuticals, Inc. - COM (ELDN)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
18.3M
Holdings value Q2 2024
$48.2M
Value change Q2 2024
+$22.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
31
Number of buys Q2 2024
1
Number of sells Q2 2024
0
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 69.5K $173K +$28.6K $2.49 2
2024 Q2 18.3M $48.2M +$22.9M $2.64 31
2024 Q1 9.6M $19.8M +$915K $2.06 28
2023 Q4 9.15M $16.5M +$507K $1.80 28
2023 Q3 8.92M $12.2M -$187K $1.37 28
2023 Q2 9.28M $12.7M +$2.93M $1.37 32
2023 Q1 6.24M $14.7M -$15.1K $2.36 29
2022 Q4 6.25M $14.4M -$300K $2.28 27
2022 Q3 6.27M $17.3M -$726K $2.76 27
2022 Q2 6.53M $15.9M -$1.24M $2.44 28
2022 Q1 7M $27.6M -$4.35M $3.94 31
2021 Q4 7.88M $34.7M -$3.53M $4.41 35
2021 Q3 8.43M $52.1M -$6.53M $6.18 30
2021 Q2 9.42M $74.5M +$5.45M $7.91 29
2021 Q1 8.32M $89M +$88.6M $10.70 32
2020 Q4 36.1K $556K +$556K $15.40 1